The most significant shift in U.S. marijuana policy is drawing closer, but one major obstacle remains in reform’s way: the Drug Enforcement Administration.
On Aug. 29, the U.S. Department of Health and Human Services (HHS) responded to President Joe Biden’s October 2022 call for a federal review of marijuana scheduling with a revolutionary pronouncement: The drug should be reclassified as a Schedule 3 controlled substance.
Now, the federal government’s first official acknowledgment that marijuana has medicinal value goes to the DEA, the arm of the Justice Department that’s most closely associated with the country’s war on drugs.
ADVERTISEMENT
DEA Administrator Anne Milgram and federal attorneys will consider relevant questions of law and policy in a review of indeterminate length.
How long the DEA might take to form a response is an open question, though experts told MJBizDaily that an initial proposed rule could be issued by the
Read full article on Marijuana Business Daily
